Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ
J Natl Cancer Inst. 2002 94 (13): 981-90

PMID: 12096083 · DOI:10.1093/jnci/94.13.981

MeSH Terms (15)

Aged Aged, 80 and over Computer Simulation Humans Incidence Male Mass Screening Models, Statistical Population Surveillance Prostate-Specific Antigen Prostatic Neoplasms SEER Program Sensitivity and Specificity Survival Rate United States

Connections (1)

This publication is referenced by other Labnodes entities: